📋 Tender Overview
Contract awarded for Framework agreement for medications for the genitourinary system and hormones for a period of 24 months lot-0007, title: cetirizine bottle 10mg/ml oral drops, description: under framework agreement minimum quantity 75 bottles - maximum quantity 150 bottles. lot-0019, title: gliclazide tablets 60 mg tablets, description: under framework agreement minimum quantity 800 tablets - maximum quantity 1600 tablets. lot-0024, title: levothyroxine na tablets 100 mcg tablets, description: under framework agreement minimum quantity 8000 tablets - maximum quantity 16000 tablets. lot-0025, title: levothyroxine na tablets 25 mcg tablets, description: under framework agreement minimum quantity 8000 tablets - maximum quantity 16000 tablets. lot-0026, title: levothyroxine na tablets 50 mcg tablets, description: under framework agreement minimum quantity 8000 tablets - maximum quantity 16000 tablets. lot-0028, title: l-ornithine-l-aspartate vials 500mg/ml injectable/infusion solution, description: under framework agreement minimum quantity 500 vials - maximum quantity 1000 vials. lot-0036, title: oxytocin vial 1 ui/ml injectable/infusion solution, description: under framework agreement minimum quantity 100 vials - maximum quantity 200 vials. lot-0056, title: empagliflozin tablets 25mg tablets, description: under framework agreement minimum quantity 2000 tablets - maximum quantity 4000 tablets. lot-0057, title: empagliflozin tablets 10mg tablets, description: under framework agreement minimum quantity 2000 tablets - maximum quantity 4000 tablets. estimated value excluding vat: 22280.00 ron.Framework agreement for medications for the genitourinary system and hormones for a period of 24 months
